Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.
Company Details
- Employees
- 201
- Founded
- -
- Address
- 1150 Eastlake Ave E,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- spans infrastructure.
- HQ
- Seattle, Washington
Umoja Biopharma Questions
Umoja Biopharma's LinkedIn profile is https://www.linkedin.com/company/umoja-biopharma
Umoja Biopharma has
201 employees.
View email and phone details for 201
employees at Umoja Biopharma.
Umoja Biopharma's industry is
Biotechnology Research
Umoja Biopharma's top competitors are
Normunity,
Be Biopharma,
Shape Therapeutics Inc.,
Timberlyne Therapeutics,
Light Horse Therapeutics,
Ouro Medicines,
Sana Biotechnology, Inc.,
Kardigan,
Enveda,
Tune Therapeutics.
Umoja Biopharma's categories are Biotechnology Research
Umoja Biopharma's founding year is 2019
